Has Ivan Samcam, MD received payments from drug or device companies?

Yes. Drug and device makers reported $50,570 in general payments to Ivan Samcam, MD across 825 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ivan Samcam, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ivan Samcam, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ivan Samcam, MD

Interventional Pain Medicine · Naples, FLNPI 1194131730

Payments from drug & device makers

$50,570in general payments, 2019–2025

Across 825 payments — averaging $61.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$17K
Boston Scientific$7K
Vertiflex, Inc.$3K
MML US, Inc.$2K
Relievant Medsystems, Inc.$2K
AbbVie$2K
plus $17K from 54 others

What the payments were for

Consulting fees$16,51333%
Speaking & faculty fees$3,1886%
Travel & lodging$7,79315%
Food & beverage$22,84945%
Education$1040%
Entertainment$1240%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	18	$17,252
Boston Scientific	91	$6,698
Vertiflex, Inc.	30	$2,510
MML US, Inc.	15	$2,423
Relievant Medsystems, Inc.	26	$2,382
AbbVie(2 entities)	94	$1,861
Abbott	66	$1,618
Vertos Medical, Inc.	14	$1,617
Nevro Corp.	34	$1,325
Spinal Simplicity, LLC	2	$1,169
Medtronic(2 entities)	17	$1,061
Painteq LLC	33	$689
Teva Pharmaceuticals USA, Inc.	23	$613
UCB, Inc.	17	$606
Eisai Inc.	25	$564
Stimwave Technologies Incorporated	14	$550
Curonix LLC	13	$431
Amgen(2 entities)	20	$417
Takeda Pharmaceuticals U.S.A., Inc.	21	$415
Octapharma USA, Inc.	9	$386
Scilex Pharmaceuticals Inc.	22	$379
Tersera Therapeutics LLC	15	$366
Biotronik NRO, Inc.	17	$333
Collegium Pharmaceutical, Inc.	13	$330
Saluda Medical Americas, Inc.	6	$328
Pfizer	23	$323
AstraZeneca	10	$314
GE HealthCare	12	$299
Alnylam Pharmaceuticals Inc.	12	$271
Radius Health, Inc.	10	$261
VGI Medical, LLC	2	$243
Foundation Fusion Solutions, LLC	3	$209
Nalu Medical, Inc.	3	$167
Lilly USA, LLC	10	$157
Argenx US, Inc.	5	$156
Fidia Pharma USA Inc.	10	$132
Biohaven Pharmaceuticals, Inc.	2	$131
Lundbeck LLC	5	$120
Globus Medical	4	$97
Biodelivery Sciences International, Inc.	1	$93
Merit Medical Systems Inc	3	$87
Averitas Pharma Inc.	3	$83
Otsuka America Pharmaceutical, Inc.	4	$79
Tanabe Pharma America, Inc.	3	$74
Neurocrine Biosciences, Inc.	2	$70
Forte Bio-pharma LLC	1	$70
Azurity Pharmaceuticals, Inc.	3	$67
Zyla Life Sciences, Inc.	4	$58
Orexo US, Inc.	4	$55
Kaleo, Inc.	4	$53
Biohaven Pharmaceutical Holding Company Ltd.	3	$53
SPR Therapeutics, Inc	2	$48
Novartis	3	$48
Hikma Pharmaceuticals USA	2	$45
Catalyst Pharmaceuticals, Inc.	1	$42
Cala Health, Inc.	2	$36
Revance Therapeutics, Inc.	1	$31
SK Life Science, Inc.	1	$30
West Therapeutics Development, LLC	2	$30
Si-bone, Inc.	1	$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPINEJACK$15,938
Intracept$7,171
ReActiv8$2,135
mild Device Kit$2,014
Superion ISS$1,937
HA MINUTEMAN G3-R$1,169
Senza Spinal Cord Stimulation System$481
OPTABLATE$396
INTELLIS ADAPTIVESTIM$297
Evoke$278
INTELLIS$227
PAINTEQ$216
TRIATHLON$203
VerteLoc$155
Superion Indirect Decompression System$149
OCTAGAM IMMUNE GLOBULIN (HUMAN)$140
Intracept RF Probe$136
PANZYGA$128
Nalu Neurostimulation System$127
AJOVY$125

How this compares

$50,570 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$796,553

Medicare patients

758

Services billed

8,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	155	$2,797
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	98	$1,721
Gabapentin	186	$1,485
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	54	$762
Methocarbamol	75	$593
Methylprednisolone	80	$496
Duloxetine Hcl	26	$341
Tramadol Hcl	72	$227
Diclofenac Sodium	37	$223
Celecoxib	11	$170
Mupirocin	17	$104
Cyclobenzaprine Hcl	13	$62
Doxycycline Hyclate	12	$54
Diazepam	42	$45

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Naples

Ajai NemaniNaples$26K
Ajay AntonyGainesville$1.9M
Louis RasoJupiter$1.6M
Gilbert MbeoOrlando$1.4M
George BesongOrange City$1.2M
Gary KaoMiddleburg$1.1M
Neil EllisTampa$1.1M
Alexis RentaBoynton Beach$1.1M
Michael EspositoVero Beach$1M
Jose RiveraTampa$993K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →